2018

11/23/2018 Guerbet launches a new multi-patient solution, with no compromise on efficiency and patient safety

Presented for the first time at the Radiological Society of North America meeting (RSNA, Chicago, November 25–30, 2018), this solution broadens Guerbet’s multi-patient range Villepinte, November 23, 2018 (8:00 CET) - Guerbet, a global specialist in contrast agents and solutions for medical...

[more]


11/21/2018 Guerbet launches Contrast&Care® 2.0

Guerbet launches Contrast&Care® 2.0, the new version of its digital solution for managing the injection of contrast media for medical imaging centersContrast&Care® 2.0 will be presented at the RSNA (Radiological Society North America) Congress in Chicago, to be held from November 25th to...

[more]


11/08/2018 Guerbet teams around the world celebrate the International Day of Radiology

Today marks the 123th anniversary of X Ray by the physician Wilhelm Röntgen, and this year the International Day of Radiology highlights the essential role that imaging professionals play in the detection, diagnosis and management of cardiac diseases, increasing the quality of care and treatment...

[more]


10/25/2018 Revenue at 30 September 2018

€614.3M at constant exchange rates, up 2.1%   Villepinte, 25 October 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €581.4M for the first nine months of the 2018 financial year, down 3.3% due to a highly...

[more]


10/08/2018 Guerbet will present its comprehensive ranges and innovative solutions for diagnostic and interventional medical imaging at the annual JFR congress

Villepinte (France), October 8, 2018 – Guerbet, the global specialist in contrast media and solutions for diagnostic and interventional medical imaging, will be taking part in the national 2018 JFR event dedicated to radiology from October 12 to 15 at the Palais des Congrès in Paris. The group will...

[more]


09/25/2018 2018 half-year results

> Sales growth at constant exchange rates> EBITDA margin in line with announced targets> Significant progress in implementing the GEAR 2023 plan Villepinte, September 25, 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, has...

[more]


09/20/2018 Guerbet to present its innovative solutions offering for interventional imaging at CIRSE 2018

Guerbet, the global specialist in contrast media and solutions for diagnostic and interventional medical imaging, has announced its presence at the 2018 annual congress of the CIRSE (Cardiovascular & Interventional Radiological Society of Europe), to be held from September 22 to 25, 2018 in...

[more]


Displaying results 1 to 7 out of 23
<< First < Previous 1-7 8-14 15-21 22-23 Next > Last >>